| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695107 | Gynecologic Oncology | 2017 | 9 Pages |
Abstract
These results support the hypothesis that intratumoral drug distribution following IP treatment is diffusion-controlled. An implanted device that continuously delivers low doses of IP chemotherapy would, therefore, be maximally effective against microscopic tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Laura M. Tanenbaum, Aikaterini Mantzavinou, Kriti S. Subramanyam, Marcela G. del Carmen, Michael J. Cima,